The Use of In Vitro Systems for Evaluating Haematotoxicity

Anon. (1994). ECVAM News and Views. ATLA 22, 7–11.

Sachs L. (1987). The molecular control of blood cell development. Science 238, 1374–1379.

Metcalf D. (1984). The basic biology of haemopoiesis. In The Haemopoietic Colony Stimulating Factors (ed. Metcalf D. ), pp. 1–26. Amsterdam: Elsevier.

Dexter T.M. , and Moore MAS. (1977). In vitro duplication and cure of haemopoietic defects in genetically anaemic mice. Nature 269, 412–414.

Quesenberry P.J. (1990). Stromal cells in long-term bone marrow cultures. In Handbook of the Haemopoietic Microenvironment (ed. Tavassoli M. ), pp. 253–285. Clifton, NJ, USA: Humana

Lord B.I. , and Testa N.G. (1988). The hemopoietic system: structure and regulation. In Hemopoiesis: Long-term Effects of Chemotherapy and Radiation (ed. Testa N.G. , Gale R.P. ), pp. 1–26. New York: Marcel Dekker.

Dellmann H.D. , ed. (1993). Textbook of Veterinary Histology, 4th edn., p. 66. Malvern, PA, USA: Lea & Febinger.

Trentin J.J. (1970). Influence of hematopoietic organ stroma on stem cell differentiation. In Regulation of Hematopoiesis (ed. Gordon A.S. ), pp. 161–186. New York: Appleton-Century-Crofts.

Bradley T.R. , and Metcalf D. (1966). The growth of mouse bone marrow cells in vitro. Australian Journal of Experimental Biology and Medical Science 44, 287–300.

Ichikawa Y. , Pluznik D.H. , and Sachs L. (1966). In vitro control of the development of macrophage and granulocyte colonies. Proceedings of the National Academy of Science 56, 488–495.

Parchment R.E. , Huang M. , & Erickson-Miller C.L. (1993). Roles for in vitro myelotoxicity tests in preclinical drug development and clinical trial planning. Toxicologic Pathology 21, 241–250.

Deldar A. , House R.V. , and Wierda D. (1995). Bone marrow colony-forming assays. Methods in Immunotoxicology 1, 227–250.

Deldar A. (1994). Drug-induced blood disorders: review of pathogenetic mechanisms and utilisation of bone marrow cell culture technology as an investigative approach. Current Topics in Veterinary Research 1, 83–101.

Deldar A. , and Stevens C.E. (1993). Development and application of in vitro models of hematopoiesis to drug development. Toxicologic Pathology 21, 231–240.

Boorman G.A. , Luster M.I. , Dean J.H. , and Campbell M.L. (1982). Assessment of myelotoxicity caused by environmental chemicals. Environmental Health Perspectives 43, 129–135.

Deldar A. , Stevens C.E. , and Rodocker K.B. (1991). Canine BFU-E progenitors: adaptation of a reproducible assay and anatomical distribution. International Journal of Cell Cloning 9, 579–593.

Deldar A. , Stevens C.E. , and Beineke P.J. (1990). Comparative distribution of marrow CFU-E and CFU-GM progenitors in different anatomic sites in the dog. International Journal of Cell Cloning 8, 196–208.

Spooncer E. , Boettiger D. , and Dexter T.M. (1992). Isolation and culture of factor dependent haemopoietic cell lines. In Hemopoiesis: A Practical Approach (ed. Testa N.G. , Molineaux D.P. ), pp. 107–121. Oxford: IRL Press.

Aizawa S. , Yaguchi M. , Nakano M. , Toyama K. , Inokuchi S. , Imai T. , Yasuda M. , Nabeshima R. , and Handa H. (1994). Hematopoetic supportive function of human bone marrow stromal cell lines established by a recombinant SV40-adenovirus vector. Experimental Hematology 22, 482–487.

Rios M. , and Williams D.A. (1990). Systematic analysis of stromal cell lines derived from different murine adult tissues to support maintenance of hematopoietic stem cells in vitro. Journal of Cellular Physiology 145, 434–443.

Sutherland H.J. , Lansdorp P.M. , Henkelman D.H. , Eaves A.C. , and Eaves C.H. (1990). Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proceedings of the National Academy of Science 87, 3584–3588.

Pessina A. , Mineo E. , Neri M.G. , Gribaldo L. , Colombo R. , Brambilla P. , and Zaleskis G. (1992). Establishment and characterization of a new murine cell line (SR-4987) derived from marrow stromal cells. Cytotechnology 8, 93–102.

Breems D.A. , Blokland E. , Neben S. & and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells. Molecular Pharmacology 37, 255–262.

Twerdok L.E. , and Trush M.A. (1990). Differences in quinone reductase activity in primary bone marrow stromal cells derived from C57BL/6 and DBA/2 mice. Research Communications in Chemical Pathology and Pharmacology 67, 375–386.

Zhu H. , Li Y. , and Trush M.A. (1995). Characterization of benzo[a]pyrene quinone-induced toxicity to primary cultured bone marrow stromal cells from DBA/2 mice: potential role of mitochondrial dysfunction. Toxicology and Applied Pharmacology 130, 108–120.

Du D.L. , Voipe D.A. , Grieshaber C.K. , and Murphy M.J. Jr. (1991). Comparative toxicity of fastriecin, hepsulfam, and pyrazine diazohydroxide to human and murine hematopoietic progenitor cells. Investigational New Drugs 9, 149–157.

Noble C. , and Sina J.F. (1993). Usefulness of the in vitro bone marrow colony-forming assay in cellular toxicology. In Vitro Toxicology 6, 187–195.

Schoeters G.E. , van der Plaetse F. , Leppens H. , van Vlasselaer P. , & van den Heuvel R. (1995). Haemopoietic and osteogenic toxicity testing in vitro using murine bone marrow cultures. Toxicology in Vitro 9, 421–428.

Deldar A. , Stevens C.E. , and Zack P.M. (1995). Differential haematotoxicity by a nucleoside in progenitor cell assays from the rat, dog, non-human primates and human. Veterinary Pathology 32, 546–553.

Du D.L. , Volpe D.A. , Grieshaber C.K. , and Murphy M.J. Jr. (1990). Effects of L-phenylalanine mustard and L-buthionine sulfoximine on murine and human hematopoietic cells in vitro. Cancer Research 50, 4038–4043.

Goris H. , Bungart B. , Loeffler M. , Schmitz S. , and Nijhof W. (1990). Migration of stem cells and progenitors between marrow and spleen following thiamphenicol treatment of mice. Experimental Hematology 18, 400–407.

Pessina A. , Neri M.G. , Muschiato A. , and Raimondi A. (1983). Inhibition of granulocytic-macrophagic precursor cells (CFU-C) by heat-labile enterotoxin (LT) produced by Escherichia coli. Biomedicine and Pharmacotherapy 37, 447–452.

Pessina A. , Neri M.G. , Muschiato A. , Mineo E. , and Cocuzza G. (1989). Effect of fluoroquinolones on the in vitro proliferation of myeloid precursor cells. Journal of Antimicrobial Chemotherapeutics 24, 203–208.

Dainiak N. , Worthington M. , Riorden M.A. , Kreczko S. , and Goldman L. (1988). 3-Azido-3'deoxythimidine (AZT) inhibits the proliferation in vitro of human haematopoietic progenitor cells. British Journal of Haematology 69, 299–304.

Parent-Massin D.M. , Sensebé L. , Leglise M.C. , Guern G. , Berthou C. , Riché C. , and Abgrall J.F. (1993). Relevance of in vitro studies of drug-induced agranulocytosis. Drug Safety 9, 463–469.

Pisciotta A.V. , Konings S.A. , Ciesemier L.L. , Cronkite C.E. , and Lieberman J.A. (1992). On the possible mechanisms and predictability of clozapine-induced agranulocytosis. Drug Safety 8, Suppl. 1, 33–44.

Eliopoulos G. , Coulocheri S. , Eliopoulos A. , Vaiopoulos G. , Tsantali C. , & Anagnou N (1991). Impaired production of GM-CSA in bone marrow and peripheral monocytes in two patients with severe congenital neutropenia. Haematologia Budapest 24, 63–70.

Ghizzi A. , de Caro L. , Bensi L. , and Berti P. (1991). L'azione in vitro dell'acido folico sulla dinamica proliferativa delle CFU-GM midollari umane nella granulocitopenia da propifenaznne. Bolletlmo della Societa Itahana di Biologia Sperimentale 67, 553–560.

Knospe W.H. , Husseini S.G. , Chiu K.M. , and Fried W. (1994). Immunologically mediated aplastic anemia in mice: evidence of hematopoietic stromal injury and injury to hematopoietic stem cells. Experimental Hematology 22, 573–581.

Gordon M.Y. (1994). Stem cells and the microenvironment in aplastic anaemia. British Journal of Haematology 86, 190–192.

Gibson F.M. , Scopes J. , Daly S. , Ball S.E. , & Gordon-Smith E.C. (1994). In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3. Experimental Hematology 22, 302–312.

Bacigalupo A. , Piaggio G. , Podesta M. , Raffo M.R. , Tedone E. , Sogno G. , Benvenuto F. , Figari O. , Grassia L. , Bagnava G.P. , Strippoli P. , Bonsi L. , Brizzi M.F. , Avanzi G.C. , Timeus F. , Ramenghi U. , Paolucci G. , Pegoraro L. , & Gabutti V. (1993). In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia. Stem Cells 11, Suppl. 2, 175–179.

Bacigalupo A. , Piaggio G. , Podesta M. , van Lint M.T. , Valbonesi M. , Lercari G. , Mori P. G. , Pasino M. , Franchmi E. , Rivabella L. , Figaro O. , Sogno G. , Raffo M.R. , and Marmont A.M. (1993). Collection of peripheral blood hematopoietic progenitors (PBHP) from patients with severe aplastic anemia (SAA) after prolonged administration of granulocyte colony-stimulating factor. Blood 82, 1410–1414

Hauser S.P. , Udupa K.B. , and Lipschitz D.A. (1994). Effects of ceftazidime, a betalactam antibiotic, on murine haemopoiesis in vitro. British Journal of Haematology 86, 733–739.

Cunningham J.M. , Refaie F.N. , Hunter A.E. , Sheppard L.N. , and Hoffbrand A.V. (1994). Differential toxicity of alpha-keto hydroxypyridine iron chelators and desferrioxamine to human haemopoietic precursors in vitro. European Journal of Haematology 52, 176–179.

Parent-Massin D.M. , and Thouvenot D. (1995). In vitro toxicity of tricothecenes on rat haematopoietic progenitors. Food Additives and Contaminants 12, 41–49.

Lange W. , Brugger W. , Rosenthal F.M. , Kanz L. , & Lindemann A. (1992). The role of cytokines in oncology. In Concise Reviews in Clinical and Experimental Hematology (ed. Murphy M.J. ), pp. 13–26. Dayton, OH, USA: AlphaMed Press.

Okada S. , Nakauchi H. , Nagayoshi K. , Nakamura M. , Miura Y. , and Suda T. (1992). Synergistic effect of IL-3 and IL-6 on higly enriched murine hemopoietic progenitors. Experimental Hematology 20, 546–551.

Migliaccio G. , Migliaccio A.R. , Valinsky J. , Langley K. , Zsebo K. , Visser J.W.M. , and Adamson J.W. (1991). Stem cell factor induces proliferation and differentiation of highly enriched murine hematopoietic cells. Proceedings of the National Academy of Science 88, 7420–7424.

Pessina A. , Neri M.G. , Muschiato A. , Brambilla P. , Marocchi A. , and Mocarelli P. (1986). Colony stimulating factor produced by murine adrenocortical tumor cells. Journal of the National Cancer Institute 76, 1095–1099.

Eaves C. , Fraser C. , Udomsakdi C. , Sutherland H. , Barnett M. , Szilvassy S. , Hogge D. , Lansdorp P. , and Eaves A. (1992). Manipulations of the hematopoietic stem cell in vitro. Leukemia 6, 27–30.

Serrano F. , Varas F. , Bernad A. , and Bueren J.A. (1994). Accelerated and long-term hematopoietic engraftment in mice transplanted with ex-vivo expanded bone marrow. Bone Marrow Transplantation 14, 855–862.

Palsson B.O. , Paek S-H. , Schwartz R.M. , Pals-son M. , Lee G-M , Silver S. , and Emerson S.G. (1993). Expansion of human bone marrow progenitor cells in a high cell density continuous perfusion system. Bio/Technology 11, 368–372.

Brenner M.K. , and Rill D.R. (1993). Gene marking to improve the outcome of autologous bone marrow transplantation. Journal of Hematolherapy 2, 7–17.

Goodman S. , Xiao X. , Donahue R.E. , Moulton A. , Miller J. , Walsh C. , Young N.S. , Samulski R.J. , and Nienhus A.W. (1994). Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 84, 1492–1500.

Ward M. , Richardson C. , Pioli P. , Smith L. , Podda S. , Goff S. , Hesdorffer C. , and Bank A. (1994). Transfer and expression of the human multiple drug resistance gene into human CD34⁺ cells. Blood 84, 1408–1414.

Mickisch G.H. , Licht T. , Merlino G.T. , Gottesman M.M. , and Pastan I. (1991). Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency and toxicity. Cancer Research 51, 5417–5424.

Keating A. , Horsfall W. , Hawley R.G. , and Toneguzzo F. (1990). Effect of different promoters on expression of genes introduced into hematopoietic and marrow stromal cells by electroporation. Experimental Hematology 18, 99–102.

Pahl H.L. , Burn T.C. , and Tenen D.G. (1991). Optimization of transient transfection into human myeloid cell lines using a luciferase reporter gene. Experimental Hematology 19, 1038–1041.

Takahashi M. , Furukawa T. , Saitoh H. , Aoki A. , Koike T. , Mariyama Y. , and Shibata A. (1991). Gene transfer into human leukemia lines by electroporation: experience with exponentially decaying and square wave pulse. Leukemia Research 15, 507–513.

Takahashi M. , Furukawa T. , Nikkuni K. , Aoki A. , Nomoto N. , Koike T. , Mariyama Y. , Shinada S. , and Shibata A. (1991). Efficient introduction of a gene into hematopoietic cells in S-phase by electroporation. Experimental Hematology 19, 343–346.

Takahashi M. , Furukawa T. , Tanaka I. , Nikkuni K. , Aoki A. , Kishi K. , Koike T. , Mariyama Y. , and Shibata A. (1992). Gene introduction into granulocyte-macrophage progenitor cells by electroporation: the relationship between introduction efficiency and the proportion of cells in S-phase. Leukemia Research 16, 761–767.

Parchment R.E. , Volpe D.A. , LoRusso P.M. , Erickson-Miller C.L. , Murphy M.J. Jr. , & Grieshaber C.K. (1994). In vivo–in vitro correlation of myelotoxicity of 9-methoxypyrazoloacridine (NSC-366140, PD115934) to myeloid and erythroid hematopoietic progenitors from human, murine and canine marrow. Journal of the National Cancer Institute 86, 273–280.

Collins J.M. , Grieshaber C.K. , and Chabner B.A. (1990). Pharmacologically guided Phase I clinical trials based upon preclinical drug development. Journal of the National Cancer Institute 82, 1321–1326.

Kearns C.M. , Gianni L. , and Egorin M.J. (1995). Paclitaxel pharmacokinetics and pharmacodynamics. Seminars in Oncology 22, Suppl. 6, 16–23.

Wall J.G. , Burris H.A. , von Hoff D.D. , Rodriquez G. , Kneuper-Hall R. , Shaffer D. , O'Rourke T. , Brown T. , Weiss G. , Clark G. , McVea S. , Brown J. , Johnson R. , Friedman C. , Smith B. , Mann W.S. , and Kuhn J. (1992). A Phase I clinical and pharmacokinetic study of the toposiomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days. Anticancer Drugs 3, 337–345.

Rowinsky E.K. , Grochow L.B. , Hendricks C.B. , Ettinger D.S. , Forastiere A.A. , Hurowitz L.A. , McGuire W.P. , Sartorius S.E. , Lubejko B.G. , Kaufmann S.H. , and Donehower R.C. (1992). Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor. Journal of Clinical Oncology 10, 647–656.

Allegra C.J. (1990). Antifolates. In Cancer Chemotherapy: Principles and Practice (ed. Chabner B.A. , Collins J.M. ), pp. 110–153. Malvern, PA, USA: JB Lippincott Company.

Koury M.J. , and Bondurant M.C. (1990). Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248, 378–381.

Crompton T. (1991). IL-3 dependent cells die by apoptosis on removal of their growth factor. Growth Factors 4, 109–116.

Gianni L. , Vigano L. , Surbone A. , Ballinari D. , Casali P. , Tarella C. , Collins J.M. , and Bonadonna G. (1990). Pharmacology and clinical toxicity of 4’-iodo-4’-deoxydoxorubicin: an example of successful application of pharmacokinetics to dose escalation in Phase I trials. Journal of the National Cancer Institute 82, 469–477.

Mi Z. , and Burke T.G. (1994). Differential interaction of camptothecin lactone and carboxylate forms with human blood components. Biochemistry 33, 10,325–10,336.

Mi Z. , and Burke T.G. (1994). Marked interspecies variations concerning the interaction of camptothecin with serum albumin: a frequency-domain fluorescence spectroscopic study. Biochemistry 33, 12,540–12,545.

Burke T.G. , and Mi Z. (1994). The structural basis of camptothecin interactions with human serum albumin: impact on drug stability. Journal of Medicinal Chemistry 37, 40–46.

Grande T. , and Bueren J.A. (1994). Involvement of the bone marrow stroma in the residual hematopoietic damage induced by irradiation of adult and young mice. Experimental Hematology 22, 1283–1297.

Grande T. , and Bueren J.A. (1995). Analysis of the hematopoiesis in mice irradiated with 500mGy of X-rays at different stages of development. Radiation Research 143, 327–333.

Yang F.T. , Lord B.I. , and Hendry J.H. (1995). Gamma irradiation of the fetus damages the developing hemopoietic microenvironment rather than the hematopoietic progenitor cells. Radiation Research 141, 309–313.

van den Heuvel R. , Schoeters G. , Leppens H. , and Vanderborgth O. (1991). Stromal cells in long-term cultures of livers, spleen, and bone marrow at different developmental ages have different capacities to maintain GM-CFC proliferation. Experimental Hematology 19, 115–121.

Deldar A. , Stevens C. , Rodocker K. , Lopez C. , Bendele R. , and Bloom J. (1989). Comparative effects of AZT on marrow progenitor cells in dog, monkey and rat models. Blood 74, 316a.

Balls M. , Blaauboer B. , Brusick D. , Frazier J. , Lamb D. , Pemberton M. , Reinhardt C. , Roberfroid M. , Rosenkranz H. , Schmid B. , Spielmann H. , Stammati A-L. , & Walum E. (1990). Report and recommendations of the CAAT/ERGATT workshop on the validation of toxicity test procedures. ATLA 18, 313–337.

Du D.L. , Volpe D.A. , Grieshaber C.K. , and Murphy M.J. Jr. (1992). In vitro toxicity of 3-azido-3’-deoxythymidine (AZT), Carbovir, and 2,3’-dideoxythymidine (d4T) to human and murine hematopoietic progenitor cells. British Journal of Haematology 80, 437–445.

Du D.L. , Volpe D.A. , Grieshaber C.K. , and Murphy M.J. Jr. (1990). In vitro myelotoxicity of 2’,3,3’-dideoxynucleosides on human hematopoietic progenitor cells. Experimental Hematology 18, 832–836.

Volpe DA , Cole K. , Sandeen A. , and Kohn E.C. (1995). In vitro and in vivo myelotoxicity of CAI to human and murine hematopoietic progenitor cells. American Journal of Hematology 50, 277–282.

Volpe D.A. , Du D.L. , Grieshaber C.K. , and Murphy M.J. Jr. (1994). In vitro characterization of the myelotoxicity of cyclopentenyl cytosine (CPE-C). Cancer Chemotherapeutics and Pharmacology 34, 103–108.

Volpe D.A. , Du D.L. , Zurlo M.G. , Mongelli N. , and Murphy M.J. Jr. (1992). Comparative in vitro myelotoxicity of FCE 24517, a distamycin derivative, to human, canine, and murine hematopoietic progenitor cells. Investigational New Drugs 10, 255–261.

Horikoshi A. , and Murphy M.J. Jr. (1982). Comparative efffects of chemotherapeutic drugs on human and murine hematopoietic progenitors in vitro. Chemotherapy 28, 480–501.